Paclitaxel mushonga une simba unorwisa cancer wave chikamu chakakosha chekurapa cancer yekiriniki nekuda kwemaitiro ayo akasiyana uye akawanda ekurapa mabhenefiti.Mushonga uyu wakatanga wakaparadzaniswa kubva kuPacific yew tree (Taxus brevifolia) muna 1971, uye mushure memakore ekutsvagisa nekusimudzira, wakashandiswa zvakanyanya munzvimbo dzakawanda dzegomarara.Iri bepa richasuma nzvimbo huru dzekushandisa dzepaclitaxel APIuye basa rayo rinokosha munzvimbo idzi.
1. Ovarian Cancer Treatment:
Paclitaxelinowanzoshandiswa kurapa ovarian cancer.Inogona kushandiswa semutsetse wekutanga kurapwa kana, pamwe chete nemamwe madhiragi, seadjunct kurapa kenza yepamusoro yegomarara.Paclitaxel inonyatso kuvharidzira kukura uye kupararira kwekenza maseru nekukanganisa mitosis ye tumor cell.
2. Kurapa Gomarara Repazamu:
Kune varwere vegomarara rezamu, paclitaxel inowanzoshandiswa pamwe chete nemimwe mishonga inorwisa gomarara, kunyanya yegomarara rezamu repamusoro kana rinodzokororwa.Inobatsira kuderedza saizi yebundu uye kuvandudza kushanda kwekurapa.
3. Kurapwa kwegomarara remapapu:
Isiri-diki cell cancer yemapapu (NSCLC) imhando yakajairika yekenza yemapapu, uye paclitaxel inoshandiswa zvakanyanya semutsara wekutanga kana adjuvant kurapa kweNSCLC.Inobatsira kuderedza kukura kwemamota uye inovandudza mararamiro ekupona.
4. Kurapa gomarara rechibereko:
Paclitaxel inoshandiswa pamwe chete neCisplatin mukurapa gomarara remuchibereko, kazhinji sechikamu cheadjuvant radiation therapy.Mushonga wemusanganiswa uyu wakavandudza zvakanyanya huwandu hwekupona kwevarwere vegomarara rechibereko.
5. Kurapa gomarara remudumbu:
Paclitaxel dzimwe nguva inoshandiswa mukurapa gomarara remudumbu kana esophageal, kazhinji pamwe chete nemamwe madhiragi anopesana negomarara kuderedza kukura kwebundu uye kupararira.
6. Prostate Cancer Kurapa:
Paclitaxel ine zvakare inogona kushandiswa mukurapa cancer yeprostate, kunyanya kana cancer yapararira kune dzimwe nhengo.Inogona kudzora kukura kwemamota uye kuderedza zviratidzo.
7. Pancreatic Cancer Kurapa:
Paclitaxel inowanzoshandiswa pamwe chete nemimwe mishonga kubatsira varwere kupona pancreatic cancer.
8. Non-hodgkin lymphoma kurapwa:
Paclitaxelinoshandiswawo mukurapa kwe-non-Hodgkin's lymphoma, kazhinji pamwe chete nemamwe chemotherapy mishonga kuderedza lymphoma mass.
9. Kurapwa kwekutanga kana metastatic brain tumors:
Paclitaxel dzimwe nguva inoshandiswa kurapa ekutanga kana metastatic brain tumors, asi inoda kupihwa kuyambuka ropa-brain barriers, iyo isingakwanise kuyambuka nyore.
Mukupedzisa, paclitaxel apis ine zvakakosha mashandisirwo mundima dzinoverengeka dzegomarara.Nekukanganisa tumor cell division, inodzivirira zvinobudirira kukura uye kupararira kwekenza maseru, ichipa tariro nemikana yekurapa kuvarwere.Zvisinei,paclitaxelkurapwa kunobatanidzwawo nemamwe migumisiro, saka chirongwa chekurapa chinofanira kusarudzwa maererano nemamiriro ezvinhu chaiwo omurwere uye kurudziro yechiremba kuti awedzere kushanda uye kuderedza migumisiro yakaipa.
Ongorora: Mabhenefiti angangoitwa uye mashandisirwo anoratidzwa muchinyorwa chino anobva mumabhuku akadhindwa.
Yunnan Hande Biotechnology Co., Ltd yakatarisana nekugadzirwa kwepaclitaxel kwemakore makumi maviri nematanhatu, uye inogadzira yakazvimiririra yemiti-yakabviswa inorwisa cancer drug paclitaxel API yakabvumidzwa neUnited States FDA, European EDQM, Australia TGA, China CFDA. , India, Japan uye mamwe masangano anodzora nyika.Yunnan Hande paclitaxel, nzvimbo yekutengesa, fekitori yakananga kutengesa, kugamuchirwa kubvunza, 18187887160 (WhatsApp nhamba imwecheteyo)
Nguva yekutumira: Oct-16-2023